Processa Pharmaceuticals, Inc.
USD2.80
-0.12 (-4.11%)
CEO
George K. Ng
IPO Date
2014-03-07
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.75
Prev. Close
$2.92
Day Low
$2.70
Day High
$2.83
52W Low
$1.76
52W High
$19.63
Market Cap
$0.01B
Volume
0.03M
| 2,292 |
| $2.57 |
| 1 Jun 2026 | Ng George K | director, officer: Chief Executive Officer | P-Purchase | Acquired | 2,129 | $2.57 |
| 1 Jun 2026 | Lin Patrick | Chief Business - Strategy Off | P-Purchase | Acquired | 1,582 | $2.57 |
| 1 Jun 2026 | Guy Wendy | Chief Administrative Officer | P-Purchase | Acquired | 1,829 | $2.57 |
| 19 May 2026 | Ng George K | director, officer: Chief Executive Officer | P-Purchase | Acquired | 1,843 | $2.97 |
| 19 May 2026 | Young David | director, officer: Pres. Research & Development | P-Purchase | Acquired | 1,545 | $2.97 |
| 19 May 2026 | Lin Patrick | Chief Business - Strategy Off | P-Purchase | Acquired | 1,369 | $2.97 |
| 19 May 2026 | Guy Wendy | Chief Administrative Officer | P-Purchase | Acquired | 1,583 | $2.97 |
| 19 May 2026 | SKIBSTED RUSSELL | Chief Financial Officer | P-Purchase | Acquired | 1,984 | $2.97 |